Progress in the Structural Basis of thermoTRP Channel Polymodal Gating

• Published in: International journal of molecular sciences Vol. 24; no. 1; p. 743
• Main Authors: Fernández-Ballester, Gregorio, Fernández-Carvajal, Asia, Ferrer-Montiel, Antonio
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 01.01.2023; MDPI AG
• Subjects: Biophysical Phenomena; channel opening; Cryoelectron Microscopy; Humans; Molecular Dynamics Simulation; polymodality; Review; Temperature; thermoreceptors; Transient Receptor Potential Channels - metabolism; TRP channels; TRPM8; TRPV1; polymodality; thermoreceptors; TRPM8; TRPV1; gating mechanism; channel opening; TRP channels
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24010743

The thermosensory transient receptor potential (thermoTRP) family of ion channels is constituted by several nonselective cation channels that are activated by physical and chemical stimuli functioning as paradigmatic polymodal receptors. Gating of these ion channels is achieved through changes in temperature, osmolarity, voltage, pH, pressure, and by natural or synthetic chemical compounds that directly bind to these proteins to regulate their activity. Given that thermoTRP channels integrate diverse physical and chemical stimuli, a thorough understanding of the molecular mechanisms underlying polymodal gating has been pursued, including the interplay between stimuli and differences between family members. Despite its complexity, recent advances in cryo-electron microscopy techniques are facilitating this endeavor by providing high-resolution structures of these channels in different conformational states induced by ligand binding or temperature that, along with structure-function and molecular dynamics, are starting to shed light on the underlying allosteric gating mechanisms. Because dysfunctional thermoTRP channels play a pivotal role in human diseases such as chronic pain, unveiling the intricacies of allosteric channel gating should facilitate the development of novel drug-based resolving therapies for these disorders.